Introduction {#s1}
============

In most animals, germline cells are generated apart from the somatic lineage in early development. In contrast to mice, in which the germline is generated by inductive signals from the surrounding tissues, the *Xenopus* germline is established by inheriting specialized cytoplasm localized in the vegetal cortex of the egg. Such cytoplasm in *Xenopus* is also observed in various animals including zebrafish, nematode and fly, which is termed 'germ plasm' in general, the P-body in *Caenorhabditis elegans* and 'polar plasm' in *Drosophila melanogaster* ([@b12]). It has been demonstrated that germ plasm contains determinants required and sufficient for germline differentiation in *Drosophila* ([@b15]; [@b28]) and *Xenopus* ([@b3]; [@b36]).

In early *Xenopus* development, germ plasm at the vegetal cortex of fertilized eggs is divided into about four blastomeres through the first two cleavages, and then distributes to only one side of two daughter cells because it is present in a particular region of the cortex of blastomeres ([@b44]). Thus, the number of primordial germ cells (PGCs) harboring germ plasm remains at about four, although the size of PGCs become gradually smaller through repeated cell division until the late blastula at stage 9. Early in gastrulation, germ plasm moves from the cortex to the perinuclear region in PGCs and divides equally into two daughter PGCs in later cell divisions. PGCs incorporating germ plasm divide about three times and migrate to the genital ridge ([@b5]). The germ plasm is composed of electron dense granules, many mitochondria, and specific mRNAs and proteins. Although many molecules in germ plasm have been identified and investigated, the mechanisms of germline development remain unknown ([@b4]; [@b17]).

VASA/DDX4 of the DEAD-box RNA helicase family is a component of germ plasm and widely used as a germline marker in various animals because of its germline-specific expression ([@b7]). It has been reported that *vasa* is required for germ cell development. In fly and nematode, loss-of-function of *vasa* results in a defect of oogenesis ([@b23]; [@b35]). MVH (mouse *vasa* homolog) is present in the chromatoid body that is observable during spermatogenesis and resembles germ plasm ([@b41]). *Mvh*-null mutants show defects in spermatogenesis ([@b38]). Recently, it was also revealed that *vasa* is involved in cell cycle progression in fly ([@b30]) and sea urchin ([@b45]), and piRNA production in mice ([@b21]). In contrast, *XVLG1* (*Xenopus vasa*-like gene 1) is expressed in somatic and germ cells in *Xenopus*, although *XVLG1* is certainly a homolog of *vasa/Ddx4* ([@b14]; [@b20]). Functional inhibition of XVLG1 by an antibody results in aberrant morphogenesis of somatic cells and the loss of germ cells, suggesting that XVLG1 is involved in the differentiation of both somatic and germline cells ([@b13]; [@b14]).

DEADSouth is a DEAD-box RNA helicase belonging to DDX25, but not the VASA/DDX4 family, and its transcript is an RNA component of germ plasm in *Xenopus* ([@b25]). *DEADSouth* transcripts were initially detected prior to mitochondrial cloud formation, accumulate in the mitochondrial cloud and then co-localize to the germ plasm during early development. It is also expressed in spermatogonia, spermatocytes and spermatids in testes. In mammals, DDX25 has been identified as a gonadotropin-regulated testicular RNA helicase (GRTH) ([@b39]). Knockout of the gene results in remarkably diminished sizes of chromatoid bodies in spermatids and incomplete spermatogenesis in mice ([@b42]). It has been suggested that GRTH/DDX25 may be required to maintain chromatoid bodies in spermatogonia ([@b32]).

In this study, we focus on the function of DEADSouth in *Xenopus* germline development in relation to VASA/DDX4. By expression of mRNA encoding DEADSouth fused with mCherry fluorescent protein, we show that the DEADSouth protein is localized to the germ plasm. We show that PGCs decrease in number both in *DEADSouth*-overexpressing and -depleted embryos. The depleted embryos are deficient for translocation of germ plasm from the cortex to the perinuclear region in PGCs before midblastula transition (MBT), causing inhibited PGC division. Surprisingly, such a knockdown phenotype is rescued by expression of MVH and XVLG1, but not inactive DEADSouth helicases. The rescue is dependent on the 3′ untranslated region (3′UTR) of *DEADSouth* mRNA, which is required for localization of the injected mRNA to the germ plasm. Together, we demonstrate here that localization of DEADSouth protein is required for proper development of *Xenopus* PGCs.

Materials and Methods {#s2}
=====================

*Xenopus* embryos {#s2a}
-----------------

Adult male and female wild-type *Xenopus laevis* were purchased commercially and maintained at 22°C in circulatory tanks. Female transgenic *Xenopus laevis* expressing EGFP fused with a mitochondrial targeting signal (mito-EGFP *Xenopus*) was also used in this study ([@b37]). Because embryos from the transgenic frog had maternally supplied mitochondria with EGFP, the mitochondria-rich germ plasm was clearly visible until stage 20 under a fluorescence microscope. Embryos were obtained as described previously ([@b16]), allowed to develop at 18°C, and staged according to Nieuwkoop and Faber ([@b27]).

Preparation of constructs {#s2b}
-------------------------

*Mvh* cDNA was a gift from Drs Kuniya Abe (RIKEN BioResource Center) and Toshiaki Noce (Keio University). *DEADSouth* and *XVLG1* cDNAs were amplified by PCR using *Xenopus laevis* ovarian cDNA as a template, and cloned into pCR2.1 or pCRII vectors. Then, the ORFs and 3′UTRs were amplified by PCR using PrimeStar polymerase (TaKaRa), and inserted into appropriate regions of pCS2-based vectors such as pCS2-Venus-DEADSouth 3′UTR and pCS2-mCherry-DEADSouth 3′UTR ([@b16]) by In-Fusion technology (Clontech). pCS2-DEADSouth-DEADSouth 3′UTR and pCS2-DEADSouth-AAA-DEADSouth 3′UTR were constructed by inverse PCR with mutated primers and In-Fusion technology. The coding regions of all constructs were confirmed by sequencing. *XVLG1Δ-DS 3′UTR* and *XVLG1Δ-XVLG1 3′UTR* were generated by removing the *Eco*RV fragment of the *XVLG1* ORF from pCS2-XVLG1-DS 3′UTR and pCS2-XVLG1-XVLG1 3′UTR plasmids, respectively.

Locked nucleic acid (LNA) gapmers {#s2c}
---------------------------------

According to previous reports ([@b22]; [@b2]), antisense and mismatch LNA gapmers (19 bases each) were designed. Sequences of antisense and mismatch LNA gapmers were [TTAGC]{.ul}GGCCATCGT[TCCTT]{.ul} and [TATCC]{.ul}GGCCATCGT[TGGAT]{.ul} (modification with LNA underlined), respectively (Nippon EGT). LNA gapmers were dissolved in water at 20 µM. Ninety-two femtomoles of gapmer were injected into each embryo.

Preparation and microinjection of mRNA {#s2d}
--------------------------------------

Template plasmids were linearized by digestion with *Xho*I, and used as templates for *in vitro* mRNA synthesis with an mMESSAGE mMACHINE SP6 kit (Ambion). mRNAs of *XVLG1Δ-DS 3′UTR* and *XVLG1Δ-XVLG1 3′UTR* were labeled using a Label IT Cy3 labeling kit (Mirus). mRNAs and LNA gapmers were microinjected into the cortical region at the vegetal pole of a fertilized egg with a Nonoject II microinjector (Drummond Scientific Company). The amount of each injected mRNA per egg was determined empirically as follows. Four-hundred and sixty picograms of *Venus-DEADSouth 3′UTR* (*v-DS*), *DS-mCherry-DS 3′UTR*, *DS-mCherry-XVLG1 3′UTR* or *mCherry-DS 3′UTR*; 46 pg (for overexpression) or 92 pg (for rescue) of *DS-full*; 46 pg of *DS-stop*; 92 pg of *DS-AAA*, *Mvh-DS 3′UTR* or *DS-XVLG1 3′UTR*; 276 pg of *XVLG1-DS 3′UTR* or *XVLG1-XVLG1 3′UTR*; 3.7 ng of *Cy3-XVLG1Δ-DS 3′UTR* or *Cy3-XVLG1Δ-XVLG1 3′UTR* were injected. Injection at these doses did not affect normal development.

PGC isolation and observation {#s2e}
-----------------------------

Mito-EGFP *Xenopus* or *v-DS*-injected embryos at the indicated stages were dissected in 70% Dulbecco\'s phosphate-buffered saline without Ca^2+^ and Mg^2+^ (PBS−) and incubated for 1 hour. Then, PGCs were collected manually with a micropipette and observed under an MZ16F fluorescence stereomicroscope (Leica) equipped with a DS-5Mc digital camera (Nikon).

The diameter of PGCs was measured in images with a scale. To visualize mCherry protein, isolated PGCs were fixed in 2% paraformaldehyde/0.1 M MOPS (pH 7.5)/0.5 M NaCl at 4°C for at least 2 days, stained with 2 µg/mL Hoechst 33342 (Sigma) in PBS−, washed with PBS− and mounted in 50% glycerol/PBS−. Cells were observed under a BX60 fluorescence microscope (Olympus) equipped with a Nuance Fx digital camera (Caliper PerkinElmer).

Quantitative real-time RT-PCR {#s2f}
-----------------------------

Total RNA was extracted from 10 embryos using TRIzol (Invitrogen). One microgram of total RNA was subjected to cDNA synthesis using Ready-To-Go You-Prime First-Strand Beads with random hexamers (GE healthcare Life Science), according to the manufacturer\'s protocol. mRNA quantification was performed by a PRISM7000 Sequence Detection System (Applied Biosystems) using SYBR Premix Ex Taq (TaKaRa). Primer sequences and annealing temperatures were as follows. *DEADSouth* forward ATGGGCTTCAACAGACCTTC and reverse TCCACACGACTCAGCATAGC, 60°C; *Xpat* forward GAGGAAATTGTTGCAAGTGCTCTAAACAGG and reverse TGTCAGGAAGCATAAAATAGCCATCTGTAG, 63°C; *EF1α* forward CAGGCCAGATTGGTGCTGGATATGC and reverse GCTCTCCACGCACATTGGCTTTCCT, 66°C. Standard curves were generated for each gene by serial dilution of cDNA from uninjected stage 8 embryos. *EF1α* gene expression was used as an internal control. Each experiment was repeated three times and RNA quantification was performed twice for each experiment.

Immunostaining {#s2g}
--------------

Embryos were fixed in 4% paraformaldehyde/PBS− at 4°C overnight, washed in TPBS− (0.1% Triton X-100 in PBS−), and then incubated in blocking buffer (10% goat serum in TPBS−) at room temperature for 2 hours. Samples were treated with blocking buffer containing mouse anti-Xdazl (1:1000 dilution) ([@b26]) and rabbit anti-caspase-3 (1:1000 dilution) (Abcam) antibodies at 4°C for 3 days, washed in TPBS−, incubated in blocking buffer containing Alexa Fluor 488-conjugated anti-mouse IgG (H+L) (1:1000 dilution) (Molecular Probes) and Cy3-conjugated anti-rabbit IgG (1:1000 dilution) (Rockland) at 4°C overnight and then washed in TPBS−. Specimens were dissociated manually in PBS− and then observed under an MZ16F fluorescence stereomicroscope (Leica).

Statistical analyses {#s2h}
--------------------

The Student\'s *t*-test was carried out for all statistical analyses. One-tailed *P*-values were used for significance.

Results {#s3}
=======

Localization of DEADSouth protein in *Xenopus* PGCs {#s3a}
---------------------------------------------------

Although *DEADSouth* mRNA is localized to the germ plasm during oogenesis and early development ([@b25]), localization of the protein is unknown. Because an antibody against DEADSouth protein was not available, we expressed DEADSouth protein tagged with a fluorescent protein. To reveal the relative location of DEADSouth protein in germ plasm, we also used mito-EGFP *Xenopus* ([@b37]). Germplasm is a PGC-specific organelle enriched with mitochondria that are a useful marker of germ plasm ([@b43]; [@b6]). We prepared mRNA encoding DEADSouth protein and mCherry fluorescent protein, followed by the *DEADSouth 3′UTR* (*DS-mCherry-DS 3′UTR*), and injected it into fertilized eggs obtained by crossing a mito-EGFP female with a wild-type male. At stage 12, the germ plasm was observed in the perinuclear region of PGCs ([Fig. 1A--E](#f01){ref-type="fig"}). The mCherry signal clearly overlapped with the germ plasm and appeared to be observable in the nuclei of PGCs. This observation suggested that DEADSouth protein played a role in the nucleus and the germ plasm, but required further analysis. As a control, mCherry signal from *mCherry-DS 3′UTR* was observed throughout PGCs, but not localized to the germ plasm ([Fig. 1F--J](#f01){ref-type="fig"}). This result indicates that DEADSouth protein is localized to the germ plasm.

![DEADSouth-mCherry fusion protein is localized to the germ plasm in PGCs.\
mRNA of *DEADSouth-mCherry-DS 3′UTR* (**A--E**) or *mCherry-DS 3′UTR* (**F--J**) was injected at the vegetal pole of fertilized eggs by crossing wild-type male and mito-EGFP transgenic female *Xenopus*. PGCs were isolated from embryos at stage 12, fixed and stained with Hoechst 33342. Signals for mCherry, germ plasm (mitochondria) and nuclei are red, green and blue, respectively. Scale bars: 10 µm.](bio-02-02-191-f01){#f01}

Overexpression effects of the *DEADSouth* gene {#s3b}
----------------------------------------------

To elucidate the function of DEADSouth in PGC development, we synthesized full-length *DEADSouth* mRNA (*DS-full*) *in vitro* and injected it into the vegetal pole of fertilized eggs, together with *Venus-DEADSouth 3′UTR mRNA* (*v-DS*), to monitor PGCs in a living embryo ([@b16]). At stage 32, we externally observed that PGCs were significantly reduced in number ([Fig. 2A--D](#f02){ref-type="fig"}). The number of PGCs per embryo injected with water (control) or *DS-full* were 17.6±2.3 and 10.7±1.2 (average ± s.d., *P*\<0.001), respectively. No effect was observed in embryos injected with mRNA encoding nonsense *DEADSouth* (*DS-stop*), in which a stop codon was inserted downstream of the initial methionine of the *DEADSouth* ORF. This result indicated that the loss of PGCs was due to overexpression of DEADSouth protein.

![*DEADSouth* gene overexpression decreases the number of PGCs.\
(**A--C**) Representative examples of stage 32 embryos injected with mRNA for *v-DS* only, *v-DS* plus *DEADSouth-DS 3′UTR* (*DS-full*) and *v-DS* plus nonsense *DEADSouth-DS 3′UTR* (*DS-stop*), respectively. Anterior is toward the left. Scale bar: 1 mm. (**A′--C′**) High magnification of the areas indicated in (A--C), respectively. (**D**) The number of PGCs per embryo at stage 32 injected with the indicated mRNAs. PGC numbers were determined by externally counting from both sides. (**E**) The number of PGCs per embryo at the indicated stage without/with *DS-full* mRNA. Embryos were dissociated, and EGFP-positive and large cells were counted as PGCs. 'N' and 'n' indicate the number of experiments and total embryos examined, respectively. The *P*-value was calculated by the Student\'s *t*-test. Error bars indicate s.d. (**F**) Apoptotic PGCs in *DEADSouth*-overexpressing embryos at stage 28. PGCs were observed after dissociating the embryonic region (red box) immunostained for Xdazl and caspase-3. Arrowheads and arrows indicate Xdazl-positive/caspase-3-negative cells (non-apoptotic PGCs) and Xdazl positive/caspase-3-positive cells (apoptotic PGCs), respectively. Scale bar: 100 µm.](bio-02-02-191-f02){#f02}

To determine when the effect of *DEADSouth* gene overexpression appeared, we used mito-EGFP transgenic *Xenopus*. Embryos are more suitable for monitoring PGCs at an early stage, compared with the use of *v-DS* as a PGC tracer, because of no delayed EGFP expression. We dissociated embryos injected with *DS-full* and checked the PGCs in detail. At stages 12 and 20, no difference in PGC numbers between *DS-full* and the control (uninjected) was detected ([Fig. 2E](#f02){ref-type="fig"}). *DEADSouth*-overexpressing embryos also showed no difference in PGC size and intracellular localization of germ plasm, compared with that of the control at stages 12, 20 and 32 ([supplementary material Figs S1, S2](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20123111/-/DC1)). To determine whether the loss of PGCs resulted from apoptosis, we performed immunostaining for Xdazl and caspase-3 to detect apoptotic PGCs in *DEADSouth*-overexpressing embryos at stage 28 ([Fig. 2F](#f02){ref-type="fig"}). As expected, 17% of PGCs (10 caspase-3-positives out of 60 Xdazl-positives) were apoptotic, compared with 4.8% of PGCs in control embryos (3 out of 63). This result indicated that the loss of PGCs in *DEADSouth*-overexpressing embryos, at least partially, resulted from apoptosis.

Knockdown of *DEADSouth* with an antisense LNA gapmer {#s3c}
-----------------------------------------------------

To reveal the function of DEADSouth, we performed knockdown experiments using an antisense LNA gapmer. Because an antibody against DEADSouth is unavailable, it is difficult to evaluate the extent of knockdown after translational inhibition using morpholino oligos. Therefore, we chose an LNA gapmer as a knockdown reagent because it caused degradation of the target mRNA that was quantified easily by PCR. As shown in [Fig. 3A](#f03){ref-type="fig"}, we designed an antisense LNA gapmer targeting around the start codon of *DEADSouth* mRNA and a mismatch gapmer as a control that was not expected to act on the target.

![An LNA gapmer causes degradation of targeted *DEADSouth* mRNA.\
(**A**) Sequence alignment of *DEADSouth* mRNA (nucleotide position 29--61, accession no. AF190623), antisense and mismatch LNA gapmers and synthesized *DEADSouth* mRNA (*DS-full*). Upper letters indicate the amino acid sequence. LNA modifications and mismatch bases are underlined and in red, respectively. The sequence of *DS-full* mRNA was predicted from that of the template DNA. (**B**) Quantification of *DEADSouth* and *Xpat* mRNAs in stage 8 and 32 embryos injected with LNA gapmers. The amounts of these mRNAs were determined by real-time RT-PCR, normalized to *EF1α* mRNA levels as an internal control, and shown as relative amounts to the mRNA level in embryos injected with mismatch LNA gapmer. *P*-values and s.d. are indicated.](bio-02-02-191-f03){#f03}

First, we evaluated the extent of *DEADSouth* mRNA degradation in embryos injected with the LNA gapmer by quantitative RT-PCR. The mRNA level of *Xpat*, which is expressed in a PGC-specific manner ([@b11]), was also examined as a control. Because PGC number and the amount of germ plasm depended on the embryos and stages, the amount of *DEADSouth* mRNA was normalized to that of *EF1α* mRNA and compared between embryos injected with antisense or mismatch LNA gapmers ([Fig. 3B](#f03){ref-type="fig"}). At stages 8 and 32, *DEADSouth* mRNA levels in antisense LNA-injected embryos were reduced significantly compared with those in mismatch LNA gapmer-injected embryos (*P*\<10^−9^ at stage 8). In contrast, *Xpat* mRNA levels in both embryos were similar at stages 8 and 32. These mRNA levels in mismatch LNA gapmer-injected embryos were similar to those in uninjected embryos (data not shown). These data indicated that injection of the LNA gapmer resulted in degradation of *DEADSouth* mRNA in a sequence-specific manner. Unfortunately, stage-dependent changes of the mRNA level could not be examined because the total amount of mRNA in the embryo changed during development.

Second, we examined the effects of the LNA gapmer on PGC development by co-injection with *v-DS* as a PGC tracer. External observation at stage 32 showed that PGCs in antisense gapmer-injected embryos decreased remarkably in number compared with those in mismatch gapmer-injected embryos (antisense, 6.3±1.7; mismatch, 17.3±2.1). In addition, the reduction of PGC number in antisense gapmer-injected embryos was rescued by co-injection with *DS-full* mRNA that was ineffective for antisense gapmer targeting because of codon substitutions in the target region ([Fig. 3](#f03){ref-type="fig"}). Although this rescue was significant (*P*\<10^−5^ between antisense and antisense+*DS-full*), it appeared to be partial (*P*\<0.05 between mismatch and antisense+*DS-full*). In contrast, this reduction was not rescued by co-injection with *DS-AAA* mRNA encoding a putatively inactive helicase of DEADSouth, in which the amino acid sequence SAT was substituted with AAA in motif III ([@b29]) ([Fig. 4](#f04){ref-type="fig"}). These results clearly show that DEADSouth RNA helicase is required for proper PGC development.

![The number of PGCs is decreased by knockdown of the *DEADSouth* gene.\
(**A--D**) Representative examples of stage 32 embryos injected with the mismatch LNA gapmer, antisense LNA gapmer, antisense LNA gapmer plus *DS-full* and antisense LNA gapmer plus mutant *DEADSouth-DS 3′UTR* (*DS-AAA*), in addition to *v-DS* as a PGC-tracer, respectively. Scale bar: 1 mm. (**A′--D′**) High magnification of the areas indicated in (A--D), respectively. (**E**) The number of PGCs per embryo at stage 32 injected with the indicated LNA gapmer(s) and mRNAs. PGC numbers were determined by externally counting from both sides. (**F**) The number of PGCs per embryo at the indicated stages with mismatch or antisense LNA gapmers. The injected mito-EGFP embryos were dissociated, and EGFP-positive and large cells were counted as PGCs. N and n indicate the number of experiments and total embryos examined, respectively. *P-*values were calculated by the one-tailed *t* test. Error bars indicate s.d.](bio-02-02-191-f04){#f04}

We also dissociated *DEADSouth*-knockdown embryos at stages 12, 20 and 32, and examined PGC number per embryo and size. For stage 12 and 20 embryos, mito-EGFP transgenic *Xenopus* were used because of easier PGC tracing. PGCs from knockdown embryos at stages 12, 20 and 32 showed less increasing numbers (6.6±1.8/embryo at stage 12 to 9.3±1.7/embryo at stage 32) in contrast to control embryos (mismatch LNA injected) (10.3±2.5/embryo at stage 12 to 21.9±3.4/embryo at stage 32). At stage 12, knockdown embryos already showed that the number of PGCs was significantly decreased compared with that of the control (*P*\<0.01 between mismatch and antisense). The size distribution of *DEADSouth*-knockdown PGCs was also broader than that of the control ([Fig. 5A](#f05){ref-type="fig"}). The average size of *DEADSouth*-knockdown PGCs was clearly larger than that of control at stages 12, 20 and 32, although PGCs in both *DEADSouth*-knockdown and control embryos became smaller and the difference between them appeared to be smaller as development proceeded.

![Knockdown of the *DEADSouth* gene affects PGC division and translocation to germ plasm.\
(**A**) Size distribution of PGCs at stages 12, 20 and 32 from embryos injected with mismatch or antisense LNA gapmers. All mito-EGFP- (at stages 12 and 20) and *v-DS*-labeled (at stage 32) PGCs from the injected embryos were isolated to measure their diameter. Total PGC numbers after each injection are shown as 100%. 'n' indicates total PGC numbers. Arrows indicate average diameters from the indicated experiments. (**B**) Localization of the germ plasm in PGCs isolated from mito-EGFP embryos at stages 7 and 12, which were injected with mismatch or antisense LNA gapmers. Scale bar: 100 µm. Note that at stage 12, PGCs injected with the antisense LNA gapmer are relatively large and contain the germ plasm beneath the cell membrane, compared with perinuclear localization of the germ plasm in PGCs with the mismatch LNA gapmer. (**C**) Ratio of PGCs with three localization patterns of germ plasm from stage 12 embryos injected with mismatch or antisense LNA gapmers. According to the localization patterns, 120 and 124 PGCs with mismatch or antisense gapmers, respectively, were classified into three groups; cortex, perinucleus and intermediate (cortex-perinucleus) shown at the bottom of the panel.](bio-02-02-191-f05){#f05}

The decrease in number and increase in size of PGCs in *DEADSouth*-knockdown embryos appeared to be caused by inhibition of PGC division. In addition, we found a defect in the subcellular localization of germ plasm in *DEADSouth*-knockdown PGCs ([Fig. 5B](#f05){ref-type="fig"}). In normal development, the germ plasm is present in a particular region of the cortex in PGCs before MBT. Then, it moves to a perinuclear region and is divided equally into two daughter PGCs after MBT. The germ plasm in PGCs from embryos injected with the mismatch gapmer appeared to behave similarly to those from uninjected embryos. Quantitative analysis demonstrated that 83.4% of PGCs had germ plasm in the perinuclear region at stage 12 ([Fig. 5C](#f05){ref-type="fig"}). In contrast, only 28.2% of PGCs from *DEADSouth*-knockdown embryos showed a normal distribution of germ plasm, but the germ plasm remained in the cortex of most PGCs (60.5%). The germ plasm in *DEADSouth* knockdown-PGCs also appeared to be expanded in the cortex. These findings indicate that DEADSouth is involved in translocation of germ plasm in PGCs at MBT.

Functional substitution of *vasa* for *DEADSouth* {#s3d}
-------------------------------------------------

In *Drosophila*, the *vasa* gene encodes a DEAD-box RNA helicase that is required for germ cell development ([@b35]). *vasa* homologs have been identified in various animals and are expressed specifically in their germline. Also, in *Xenopus*, *vasa*-like gene 1 (*XVLG1*) was identified as a *vasa* homolog ([@b20]). However, *XVLG1* is not expressed in a germline-specific manner ([@b14]). Instead, *DEADSouth* was identified as another germline-specific DEAD-box RNA helicase ([@b25]). Therefore, we examined whether *vasa* genes could functionally substitute for the *DEADSouth* gene in *Xenopus*. We prepared two constructs, in which the ORF of *Mvh* or *XVLG1* was fused with *DEADSouth* 3′UTR for PGC-specific expression. Fertilized eggs were injected with the mRNA of *Mvh-DS 3′UTR* or *XVLG1-DS 3′UTR* in addition to the antisense LNA gapmer and *v-DS* as a PGC tracer, and allowed to develop until stage 32 to externally observe PGCs ([Fig. 6](#f06){ref-type="fig"}). Compared with mismatch gapmer-injected embryos (PGC number, 16.8±2.5/embryo), antisense gapmer-injected embryos showed significantly reduced PGC numbers (6.4±2.3/embryo) ([Fig. 6A](#f06){ref-type="fig"}). Surprisingly, this reduction was restored by co-injection with *Mvh-DS 3′UTR* (13.0±4.4/embryo, *P*\<0.001). Co-injection with *XVLG1-DS3′UTR* showed similar results. PGC numbers in embryos injected with the mismatch gapmer, antisense gapmer, and antisense gapmer plus *XVLG1-DS 3′UTR* were 17.1±1.6, 7.6±1.1 and 12.4±0.9, respectively ([Fig. 6B](#f06){ref-type="fig"}). Although the rescue by *XVLG1-DS 3′UTR* was partial, it appeared to be similar to that by *DS-full* (12.7±1.6/embryo). These results indicated that the function of DEADSouth in PGC development can be substituted, at least in part, by another RNA helicase such as VASA.

![Knockdown of the *DEADSouth* gene is rescued by another type of DEAD-box RNA helicase.\
(**A**) Rescue by injection of *Mvh-DS 3′UTR* mRNA. (**B**) Rescue by injection of *XVLG1* and its dependency on the 3′UTR. At stage 32, PGCs were externally counted on both sides of embryos injected with the indicated mRNAs and *v-DS* mRNA as a PGC tracer, in addition to mismatch or antisense LNA gapmers. 'N' and 'n' indicate the number of experiments and total embryos examined, respectively. *P*-values and s.d. are indicated.](bio-02-02-191-f06){#f06}

These constructs contained the 3′UTR of *DEADSouth* mRNA to ensure PGC-specific expression. Therefore, we evaluated the effect of the 3′UTR. Two constructs, in which *DEADSouth* or *XVLG1* ORFs were followed by the *XVLG1* 3′UTR, were generated and subjected to assays to assess their rescue from *DEADSouth* knockdown. Surprisingly, both *DEADSouth* and *XVLG1* ORFs fused with the *DEADSouth* 3′UTR rescued from *DEADSouth* knockdown, but could not when they were fused with the *XVLG1* 3′UTR (*DS-XVLG1 3′UTR*, 8.2±1.3/embryo; *XVLG1-XVLG1 3′UTR*, 7.7±1.3/embryo). This observation indicates that the rescue depends on the *DEADSouth* 3′UTR, because there is no distinct difference between the translational activities of the two mRNAs (data not shown).

Localization of *DEADSouth* mRNA and protein to germ plasm via the 3′UTR {#s3e}
------------------------------------------------------------------------

To elucidate whether *DEADSouth* mRNA is localized to germ plasm via its 3′UTR, we examined the behavior of fluorescent-labeled mRNA with the *DEADSouth* 3′UTR in PGCs. Nonsense mRNA encoding a partially deleted *XVLG1* ORF followed by the *DEADSouth* 3′UTR (*XVLG1Δ-DS 3′UTR*) or *XVLG1* 3′UTR (*XVLG1Δ-XVLG1 3′UTR*) was labeled with Cy3 fluorescent dye *in vitro* and injected at the vegetal pole of fertilized eggs from mito-EGFP *Xenopus*. At stage 7, we dissociated the embryos, isolated PGCs and observed Cy3-labeled mRNA in relation to the germ plasm ([Fig. 7](#f07){ref-type="fig"}). The Cy3 signal was weak and dispersed throughout PGCs containing *XVLG1Δ-XVLG1 3′UTR*. In contrast, Cy3-labeled mRNA of *XVLG1Δ-DS 3′UTR* was accumulated in the germ plasm of PGCs, as demonstrated by co-localization with the mito-EGFP signal, indicating that the 3′UTR of *DEADSouth* mRNA includes a signal to localize or anchor mRNA to the germ plasm. In addition, we examined whether localization of DEADSouth protein was dependent on localization of the mRNA. mRNA encoding a DEADSouth-mCherry fusion protein fused with the *DEADSouth* 3′UTR (*DS-mCherry-DS 3′UTR*) or *XVLG1* 3′UTR (*DS-mCherry-XVLG1 3′UTR*) was injected as described above. As shown in [Fig. 1](#f01){ref-type="fig"}, DEADSouth-mCherry fusion protein from *DS-mCherry-DS 3′UTR* mRNA was partially co-localized to the germ plasm in PGCs. DEADSouth-mCherry fusion protein from *DS-mCherry-XVLG1 3′UTR* mRNA was not localized to any region, but was distributed throughout the cells ([supplementary material Fig. S3](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20123111/-/DC1)). This observation indicates that localization of the mRNA to the germ plasm is controlled by the 3′UTR of the mRNA, which localizes DEADSouth protein to the germ plasm.

![*DEADSouth* 3′UTR localizes the mRNA to the germ plasm.\
Localization of *Cy3-labeled XVLG1Δ-DS 3′UTR* mRNA (**A--C**) and *Cy3-labeled XVLG1Δ-XVLG1 3′UTR* mRNA (**D--F**) in PGCs at stage 7. PGCs were isolated from mito-EGFP embryos injected with these mRNAs and observed for Cy3 signals (mRNA, in red) and germ plasm (mitochondria, in green). Note that the Cy3 signal is superimposed on the germ plasm in (A--C). Scale bar: 10 µm.](bio-02-02-191-f07){#f07}

Discussion {#s4}
==========

Germ plasm has been observed in oocytes of various animals including *Drosophila* and *Xenopus* ([@b12]), and is required and sufficient for germline development ([@b15]; [@b28]; [@b36]). Many transcripts have been identified as RNA components of germ plasm ([@b4]; [@b17]), and analyzed for their functions in *Xenopus* to understand the mechanisms underlying germline development ([@b10]; [@b9]; [@b1]). *DEADSouth* is one of the RNA components of *Xenopus* germ plasm ([@b25]). It is interesting that *DEADSouth* is expressed in a PGC-specific manner, instead of *XVLG1* (*vasa* homolog) that is expressed in somatic cells and PGCs during early *Xenopus* development ([@b14]). We speculated that *DEADSouth* has a function similar to that of *vasa* and focused on *DEADSouth* in *Xenopus* germline development.

Recently, we have generated a transgenic *Xenopus* carrying a gene encoding EGFP fused with a mitochondrial targeting signal. Early embryos from the female have fluorescent germ plasm that is clearly visible until stage 20, because germ plasm is enriched with mitochondria supplied maternally ([@b37]). Together with a PGC visualization technique suitable for observation from about stage 12 onward ([@b16]), it was possible to trace PGCs in a living embryo during early development. Thus, we investigated the function of *DEADSouth* in the context of PGC development.

First, we investigated the intracellular localization of DEADSouth protein by expression of DEADSouth tagged with mCherry fluorescent protein. DEADSouth-mCherry fusion protein was detected in the germ plasm of PGCs at stage 12 ([Fig. 1A--E](#f01){ref-type="fig"}). Unfortunately, we could not detect the localization at earlier stages because of low expression levels of the fusion protein. In zebrafish, *vasa* mRNA, but not its protein, is localized to the germ plasm before MBT and the protein is localized to the germ plasm at later stages ([@b19]). As a control, mCherry protein was not localized to the germ plasm and distributed throughout PGCs, although mRNA was injected into the cortex of the vegetal pole where the germ plasm was present ([Fig. 1F--J](#f01){ref-type="fig"}). These results suggest that DEADSouth protein includes a signal for localization or anchorage to the germ plasm. DEADSouth-mCherry fusion protein was also detected in the nuclei of PGCs. Considering that germ plasm contains determinants for PGC differentiation in *Drosophila* ([@b15]; [@b28]) and *Xenopus* ([@b3]; [@b36]), germ plasm migration to the nucleus at this stage suggests that some transport from the germ plasm to the nucleus triggers PGC differentiation. Because DEADSouth is an RNA helicase, it is feasible that DEADSouth is involved in the transport of RNAs from the germ plasm into the nucleus.

In mammals, *GRTH/Ddx25* is a homolog of *DEADSouth*, which is expressed exclusively in testes ([@b33]) and essential for completion of spermatogenesis ([@b42]). DDX25 protein is a shuttle protein associated with RNA and localized to chromatoid bodies in spermatogonia, which have a morphology similar to that of germ plasm ([@b34]). Amino acids regions 61--74 and 101--114 of mouse DDX25 protein have been identified as a nuclear export signal via CRM1 protein and a nuclear localization signal, respectively. We found some similarity in these regions between GRTH/DDX25 and DEADSouth, suggesting that DEADSouth functions as a shuttle protein between the germ plasm and nucleus. However, detailed studies using mutated constructs are required to evaluate whether these regions of DEADSouth play important roles in intracellular transport in PGCs. Translocation of DEADSouth from the germ plasm to the nucleus may be also regulated by phosphorylation ([@b34]). Localization of endogenous DEADSouth protein also remains unknown.

To determine the possible function of DEADSouth in PGC development, we performed overexpression experiments in which *in vitro* synthesized *DEADSouth* mRNA including the 3′UTR was injected into fertilized eggs. Injected embryos showed normal PGC numbers and sizes at stages 12 and 20 ([Fig. 2E](#f02){ref-type="fig"}; [supplementary material Fig. S1](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20123111/-/DC1)). Translocation of germ plasm from the cortex to the perinuclear region appeared to occur normally before MBT ([supplementary material Fig. S2](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20123111/-/DC1)). At stage 32, *DEADSouth*-overexpressing embryos showed a loss of PGCs, but the PGCs were normal in size and localization of the germ plasm. No PGCs were detected within the endodermal mass of *DEADSouth*-overexpressing embryos, indicating that the loss of PGCs was not due to a failure to migrate. Abnormal PGC migration is often observed at the tailbud stage in knockdown embryos for germ plasm-specific genes such as *Xdazl*, *XDead end* and *XGRIP2.1* ([@b10]; [@b9]; [@b40]). Recently, it has been shown that loss of PGCs in Nanos1-depleted embryos is due to apoptosis ([@b24]). Our results also suggest that loss of PGCs in *DEADSouth*-overexpressing embryos is, at least partially, due to apoptosis ([Fig. 2F](#f02){ref-type="fig"}). Early *Xenopus* embryos might have a mechanism by which aberrant PGCs are eliminated by apoptosis.

However, PGC abnormalities were observed at stage 12 after depleting *DEADSouth* mRNA by injection of an antisense LNA gapmer. *DEADSouth* knockdown resulted in a decrease in number and increase in size of PGCs ([Fig. 4](#f04){ref-type="fig"}; [Fig. 5A](#f05){ref-type="fig"}), but no significant decrease in the total amount of germ plasm as indicated by the *Xpat* mRNA level ([Fig. 3B](#f03){ref-type="fig"}). The diameter of *DEADSouth*-knockdown PGCs at stage 12 was about 1.5-fold longer than that of control PGCs, indicating that the volume of *DEADSouth*-knockdown PGCs was about twice as large as that of the control ([Fig. 5A](#f05){ref-type="fig"}). These results indicate that knockdown of *DEADSouth* causes inhibition of PGC division. In addition, the knockdown phenotype was rescued by expression of normal DEADSouth, but not mutated DEADSouth encoding a putative inactive RNA helicase, suggesting that helicase activity is involved in PGC division.

Because we did not observe an abnormal cleavage pattern around the vegetal pole or defects in the size and number of PGCs in *DEADSouth*-knockdown embryos until stage 7 (data not shown), we concluded that PGC division was inhibited between stages 7 and 12. Interestingly, at that time, germ plasm moves from the cortex to perinucleus in PGCs followed by PGC specification ([@b44]; [@b43]). We also found that aberrant translocation of germ plasm occurred in *DEADSouth*-knockdown embryos at stage 12, but not at stage 7 ([Fig. 5B](#f05){ref-type="fig"}). In particular, germ plasm appeared to be expanded in the cortex of *DEADSouth*-knockdown PGCs at stage 12. Such expanded germ plasm was observable more often in larger PGCs. The ratio of PGCs with germ plasm at an aberrant position was higher in *DEADSouth*-knockdown embryos than that in control embryos ([Fig. 5C](#f05){ref-type="fig"}). In *DEADSouth*-knockdown embryos, PGCs with germ plasm at the intermediate position between the cortex and perinucleus were also observable. Because translocation of germ plasm from the cortex to perinuclear region occurs prior to symmetric PGC division, we concluded that *DEADSouth* knockdown causes aberrant translocation of germ plasm, resulting in inhibited or delayed PGC division, which suggests a link between germ plasm translocation and PGC division. At later stages (stages 20 and 32), the size of PGCs in *DEADSouth*-knockdown embryos appeared to be closer to that of the control. Their germ plasm was also present at the normal position (data not shown). Such a phenotype may have been due to incomplete knockdown. Taken together, DEADSouth RNA helicase is required for proper PGC development. In particular, it is essential for germ plasm translocation required for symmetric division of PGCs after MBT. Moreover, translocation of germ plasm may be controlled via translational regulation by DEADSouth RNA helicase, which is similar to eIF4A ([@b25]).

GRTH/DDX25 protein is present in the chromatoid bodies of spermatids. In mice, *GRTH/Ddx25*-null mutation causes complete arrest of spermiogenesis and remarkably diminishes chromatoid bodies in round spermatids at the steps before arrest ([@b42]). In addition, protein components of chromatoid bodies, such as MVH and MIWI, are completely excluded from chromatoid bodies in the knockout mouse ([@b32]). Together with its function as a shuttle protein, these findings suggest that GRTH/DDX25 is essential to govern the structure of chromatoid bodies for storage and processing of mRNAs. Similarly, DEADSouth protein may be essential to maintain the structure of germ plasm in *Xenopus*, which is supported by the observation that expanded germ plasm was present in DEADSouth-depleted PGCs.

Defects in *DEADSouth*-knockdown embryos were rescued by expression of XVLG1 or MVH RNA helicase belonging to the VASA/DDX4 family, which is different from the DDX25 family, possibly because of functional redundancy among DEAD-box RNA helicases. In mice, although *Mvh* is expressed both in the ovary and testis, no defect is detected in the ovaries of *Mvh*-knockout mice, suggesting that another helicase, such as PL10/DDX3, expressed in the ovary has functional redundancy with MVH ([@b38]). Recently, it was reported that VASA/DDX4 plays a role in cell cycle progression and germline development in *Drosophila* ([@b30]) and sea urchin ([@b45]). In *Drosophila*, VASA appears to be involved in regulation of mitotic chromosome condensation/segregation in germline cells in a translation-independent manner. Furthermore, in human and *Drosophila* somatic cells, mitotic chromosome segregation is regulated similarly by Belle/DDX3 RNA helicase, instead of VASA/DDX4 ([@b31]), suggesting functional redundancy between DDX3 and DDX4 helicases in somatic and germline cells, respectively. In *Xenopus*, XVLG1, a VASA homolog, appears to be involved in general cell specification and proliferation, rather than only in germline development, based on the expression pattern and perturbation of protein function ([@b13]; [@b14]). Our results suggest that XVLG1 and DEADSouth share VASA functions, including general and germline-specific functions, respectively, in early *Xenopus* development. To clarify such a functional redundancy and sharing between DEADSouth and VASA/DDX4, rescue experiments from *vasa* deficiency by the *DEADSouth* gene would be required. In addition, it will be necessary to determine the function of Centroid that is another DEAD-box RNA helicase gene expressed in germ plasm ([@b18]).

Surprisingly, rescue from defects in *DEADSouth*-knockdown embryos depended on the 3′UTR of *DEADSouth* ([Fig. 6B](#f06){ref-type="fig"}). mRNA with the 3′UTR of *DEADSouth* was localized to the germ plasm, but mRNA with the *XVLG1* 3′UTR was not localized to the germ plasm ([Fig. 7](#f07){ref-type="fig"}). This finding indicates that the 3′UTR of *DEADSouth* contains a signal to anchor and/or localize the mRNA. Because DEADSouth protein also appears to have signal for localization to the germ plasm, the *DEADSouth* 3′UTR supports effective localization of the DEADSouth protein. We have previously demonstrated that the *DEADSouth* 3′UTR contains information for PGC-specific protein expression, probably via microRNA ([@b16]). It is very interesting to elucidate the relationship between PGC-specific expression and localization of mRNA in the context of translational regulation.

Finally, we demonstrated the utility of an antisense LNA gapmer with mito-EGFP transgenic embryos to study the functions of germ plasm-specific genes. In addition to previous methods, such as the host-transfer technique ([@b8]) and PGC labeling with EGFP ([@b16]), these tools enable us to analyze the development of PGCs in *Xenopus*.
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